Infertility Treatment Devices and Equipment Market is expected to reach US$ 1,973.68 Mn at a CAGR of 8.4% from 2020 to 2027
Infertility Treatment Devices and Equipment Market is expected to reach US$ 1,973.68 Mn at a CAGR of 8.4% from 2020 to 2027
Stay updated with breaking news from Invo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Infertility Treatment Devices and Equipment Market is expected to reach US$ 1,973.68 Mn at a CAGR of 8.4% from 2020 to 2027
/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with...
INVO Bioscience to Present at Tribe Public Event on April 13, 2021 News provided by Share this article SARASOTA, Fla., April 12, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, announced today that Steve Shum, CEO of INVO Bioscience, will present at Tribe Public's Webinar Presentation and Q&A Event titled " Democratizing Infertility - A Severely Underserved Global Market." The Event is schedu...
INVO Bioscience Obtains Regulatory Approval to Import INVOcell Into Mexico News provided by Share this article SARASOTA, Fla., March 1, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell ®, an effective and affordable treatment for patients diagnosed with infertility, today announced the Company has received approval by COFEPRIS to import INVOcell into Mexico. In late 2020, INVO Bioscience established a joint venture focused on establishing fertility centers dedic...
Share this article Share this article ResearchAndMarkets.com's offering. According to this report the global infertility treatment devices and equipment market is expected to reach US$ 1,973.68 million by 2027 from US$ 1,050.00 million in 2019; it is estimated to grow at a CAGR of 8.4% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. The key factors driving the growth of the market include increase in the incidence of infertility in both sexes and rising number of fertility clinics and infertility services wi...